Advertisements

Diclofenac EG

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Diclofenac EG

Property Description
Active ingredient Diclofenac (Sodium or Potassium salt)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Origin Synthetic (Phenylacetic acid derivative)
Common purpose Symptomatic relief of pain and inflammation
Forms Tablets, Capsules, Gels, Solutions, Suppositories

What is Diclofenac EG and What Pharmacological Class Does It Belong To?

Diclofenac EG is a preparation containing the active ingredient diclofenac, a compound that is chemically defined as a synthetic phenylacetic acid derivative. This substance belongs to the major pharmacological class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a classification that immediately establishes its general therapeutic role. Diclofenac is categorized as an NSAID and functions primarily as an analgesic and anti-inflammatory agent. The drug is clinically recognized for being among the more potent conventional NSAIDs used globally.


Diclofenac Composition and Available Forms

The active entity, diclofenac, is typically formulated as either the sodium or potassium salt and is generally supplied as a single-active-ingredient product. The salt form can influence the drug's absorption rate, with the potassium salt sometimes favored when a rapid onset of action is desired. The different dosage forms available for diclofenac are wide-ranging, encompassing oral tablets, topical gels or creams, suppositories, and various solutions. This diversity means the medication can be administered in several ways to achieve either systemic or localized relief. These different forms require distinct bases, such as solid excipients for tablets or aqueous solvents for injectable solutions.


What General Benefit Does Diclofenac EG Provide?

The general purpose of Diclofenac EG is to provide a reliable analgesic and anti-inflammatory effect to mitigate symptomatic discomfort. This action is rooted in the drug's mechanism of intervening in the body's process of generating pain and inflammation signals. A typical, neutral use scenario involves the symptomatic management of pain associated with temporary inflammatory conditions. The core benefit of this NSAID is the symptomatic management of pain and the successful reduction of inflammatory processes.

Regulatory References

  1. U.S. National Library of Medicine
  2. MedlinePlus: Diclofenac
Advertisements

What side effects are possible with Diclofenac EG?

Possible side effects and safety information

Diclofenac EG, as an Nonsteroidal Anti-inflammatory Drug (NSAID), has an official safety profile that is structured around the potential for effects across multiple physiological systems, as documented by government regulatory agencies.

Adverse Reaction Classification

Adverse reactions are classified by frequency and System-Organ Class (SOC) in official prescribing information. Common reactions (occurring in 1 out of 10 to 1 out of 100 people) often involve the Gastrointestinal System, including abdominal discomfort, nausea, vomiting, and diarrhea, as well as Nervous System effects such as headache and dizziness. Fluid retention and increased blood pressure are also listed.

Serious Adverse Reactions and Safety Patterns

The regulatory profile highlights the risk of Serious Adverse Reactions, which include potential Cardiovascular Thrombotic Events (such as myocardial infarction or stroke) and Severe Gastrointestinal Events (bleeding, ulceration, and perforation, which can be fatal). These serious events are generally classified as rare but clinically significant.

Regulatory documents state that the risk of serious cardiovascular and gastrointestinal events may increase with higher doses and longer duration of use. Gastrointestinal bleeding and ulceration are noted to occur at any time during treatment, often without warning symptoms.

Population-Specific Safety Notes

Specific safety considerations are defined for certain populations. Older patients are noted to have a higher risk of experiencing serious gastrointestinal adverse events. Furthermore, the medicine is officially not recommended in the third trimester of pregnancy due to fetal risk and is contraindicated in patients with established severe heart conditions (e.g., specific classes of congestive heart failure), according to regulatory labeling. Official labeling mandates that treatment be maintained at the lowest effective dose for the shortest possible duration.

Advertisements

Overdose and Emergency Response

If an overdose of Diclofenac EG is suspected, the official regulatory guidance is to seek immediate medical help right away or call the local emergency number. Immediate intervention is required due to the risk of severe, life-threatening outcomes documented in prescribing information.

Feature Official Regulatory Statement
Documented Manifestations: Symptoms may include nausea, vomiting, stomach pain, diarrhea, dizziness, headache, tinnitus (ringing in the ears), agitation, and confusion.
Severe Outcomes: Overdose can lead to acute renal failure, seizures, coma, and potentially fatal gastrointestinal bleeding or perforation.
Emergency Action: Seek immediate medical help right away if an overdose is suspected. Contact the local poison control center for guidance.
Antidote/Treatment: No specific antidote is known. Management is symptomatic and supportive.

Clinical Considerations

Regulatory documentation specifies that elderly patients are at a heightened risk for serious gastrointestinal complications, such as ulceration and bleeding, following an overdose. Because no specific antidote is known, clinical management focuses on supportive care, which may include measures like activated charcoal and gastric lavage if given early, and continuous monitoring of vital signs in a hospital setting for at least four to eight hours to manage potential complications effectively.

Advertisements

Therapeutic Uses of Diclofenac EG

What Diclofenac EG Treats: Main Uses and Benefits


Diclofenac EG is a medicine generally used in therapeutic domains involving certain distressing symptoms, applied in contexts where additional symptomatic support is needed to address pain and inflammation. This medication is relevant in situations where symptoms are related to inflammatory or irritative states and is commonly used across conditions presenting with acute or disruptive episodes.

The medication is generally used to help manage symptoms related to pain and inflammation in conditions that present with systemic or localized discomfort, such as joint issues, back pain, soft tissue injuries, and discomfort following minor procedures. It is applicable for conditions characterized by periods of heightened symptoms.

The medication provides support that helps ease the overall symptom burden and supports patients during episodes of heightened discomfort.

“This medication is applied in scenarios where additional management of discomfort is required, helping to manage symptoms related to inflammation and pain.”

Quick Fact: Relief for Pain and Inflammation

Diclofenac EG is applied in scenarios where additional management of discomfort is required, helping to address symptom clusters that may become intense or disruptive. It contributes to improved comfort during symptomatic periods and may assist with maintaining functional stability.

Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Diclofenac EG — Official Regulatory Information

The eligibility profile for Diclofenac EG is strictly defined by regulatory contraindications and restrictions.

Eligibility Scope

Classification Populations Condition/Rule
Contraindicated Patients with established heart failure (NYHA II–IV), Ischaemic Heart Disease, or Cerebrovascular Disease. Absolute prohibition from use (EMA/FDA).
Contraindicated Patients with active or recurrent gastrointestinal ulceration, bleeding, or perforation. Absolute prohibition from use.
Contraindicated Known hypersensitivity to Diclofenac or any other NSAID, including aspirin-induced asthma or urticaria. Absolute prohibition from use.
Contraindicated The third trimester of pregnancy and pain in the setting of CABG surgery. Absolute prohibition from use.
Contraindicated Patients with severe renal or severe hepatic failure. Absolute prohibition from use.
Not Recommended Breastfeeding women and women in the first/second trimesters of pregnancy. Use is explicitly cautioned against in labeling.
Restricted Use Older Adults (Geriatric). Eligible, but use requires special caution and the lowest effective dose for the shortest duration possible.
Restricted Use Patients with significant cardiovascular risk factors (e.g., hypertension, diabetes). Use is permitted only after careful consideration.
Restricted Use Pediatric populations (under 14 years). Systemic use is often not recommended for many indications due to age limits on specific formulations.

The official regulatory profile defines eligibility primarily through a mandatory list of contraindications that prohibit use based on severe pre-existing conditions and specific life stages. Use for all other patients, including the elderly and those with milder risk factors, is permitted but explicitly subjected to restrictions that mandate caution and the lowest dose for the shortest duration.

Advertisements

What should I know about interactions with other medicines?

Diclofenac EG Interactions with other medicines and products

Official regulatory information for Diclofenac EG details several clinically significant interaction patterns, classified primarily by their effect on drug concentration or the resulting increase in adverse event risk.

Pharmacodynamic Risk and Clearance Interference

Co-administration with warfarin and other anticoagulants presents a pharmacodynamic synergy that increases the risk of serious gastrointestinal bleeding. For this reason, concurrent use with aspirin (analgesic doses) and other non-selective NSAIDs is not generally recommended by regulators. Diclofenac is documented to reduce the renal clearance of other medicines, which can lead to an elevation of plasma concentrations for substances like lithium and increase serum concentration for digoxin.

Metabolic and Population Constraints

Metabolic interactions occur with substances that inhibit diclofenac's metabolizing enzymes. Co-administration with voriconazole, for instance, is officially documented to increase diclofenac's systemic exposure, altering its Cmax and AUC. In certain populations, the interaction with ACE Inhibitors or ARBs may be heightened: in the elderly, volume depleted, or those with renal impairment, this combination may result in the deterioration of renal function.

Formal Restrictions

Diclofenac is formally contraindicated for treating perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Additionally, the concurrent use of alcohol is linked to an officially documented increased risk of serious gastrointestinal adverse events, including ulceration.

Advertisements

Mechanism of Action

Modulating Inflammatory Signaling via COX Enzyme Inhibition

The primary mechanism of diclofenac is the competitive and reversible inhibition of Cyclooxygenase-2 ( COX-2), the inducible enzyme responsible for synthesizing pro-inflammatory prostaglandins ( PGE2). By targeting this molecular switch in the Arachidonic Acid Cascade, the drug suppresses the creation of these chemical messengers, which are central to the biosynthesis of mediators involved in inflammatory signaling. This inhibition results in a decreased concentration of chemical mediators that regulate vasodilation and vascular permeability.

Dampening Peripheral Nociceptive Response

Diclofenac's action within the COX pathway influences the peripheral nervous system. The reduction in local PGE2 levels, achieved through COX-2 inhibition, directly diminishes the sensitization of nociceptors (pain-sensing nerve endings). This physiological effect involves raising the threshold required for these nerve endings to transmit a signal to the central nervous system. This action increases the stimulus threshold required for signal transmission by peripheral nociceptors.

Advertisements

Dosage and Administration Information

How to Use Diclofenac EG: Administration Guidelines

Administration of diclofenac is governed by the principle of administering the lowest effective dose for the shortest duration necessary. Dosing and route vary significantly based on the specific condition being managed and the formulation used.


Routes, Dosing, and Frequency

The medication is utilized through several delivery methods, each with specific application rules:

  • Routes of Administration: Diclofenac is available for Oral (tablets, capsules, solution), Topical (gel, solution), Rectal (suppositories), and Parenteral (IM/IV injection) use.
  • Standard Systemic Dosing: The typical maintenance range for chronic conditions like osteoarthritis is 100 mg to 150 mg per day in divided doses, with a general maximum daily dose for oral delayed-release tablets being 150 mg.
  • Frequency: Oral systemic forms are usually administered in divided doses (two to four times daily), while extended-release forms are typically taken once daily.

Key Administration Conditions and Restrictions

Proper use requires adherence to formulation-specific rules to ensure intended drug release:

  • Form Integrity: Delayed-release and extended-release tablets must be swallowed whole and must not be crushed, chewed, or split.
  • Relation to Food: The delayed-release tablets may be taken with or without food. However, the diclofenac powder for oral solution must be taken on an empty stomach and immediately mixed with a small amount of water.
  • Topical Use: Topical gels are applied using a dosing card to measure the specified grams (e.g., 2 g or 4 g) four times daily to the affected joint area. Use in older adults generally requires starting at the lowest end of the dosing range.
Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Diclofenac EG


Evidence for Symptom Management in Osteoarthritis

Research on Diclofenac EG was explored in research related to osteoarthritis, and is largely based on short-term Randomized Controlled Trials (RCTs) and subsequent systematic reviews. These studies were used in research exploring how symptoms change over time in adults and older adults diagnosed with osteoarthritis, particularly affecting the knee and hip. The main outcomes examined were patient-reported experiences related to physical discomfort, specifically measuring changes in pain intensity, joint stiffness, and outcomes reflecting daily functioning or activity level, such as the WOMAC function scale.

What remains unclear is the long-term characterization of sustained symptomatic control. Follow-up durations were typically limited to a few months, meaning long-term effects on functional outcomes or symptom patterns are not fully established.


Evidence for Use in Acute Pain and Migraine Attacks

Research has explored the drug in very short-term, double-blind, placebo-controlled RCTs. The drug was evaluated in trials assessing short-term or episodic symptom patterns, particularly for outcomes describing episodic or acute changes, such as post-traumatic discomfort or acute migraine episodes. Research examined the speed and time to the measured change in symptoms, and the proportion of patients who required additional pain medication (rescue medication) as a key outcome.

For migraine, specific rapid-absorption formulations were studied for their effect on achieving pain-free status within the initial hours of an attack. The research is focused on immediate or very short-term relief, and follow-up durations were limited, meaning the impact on intermediate recovery is not well-characterized.


Research Gaps and What Remains Unclear

Follow-up durations were limited in many controlled trials concerning functional outcomes in chronic conditions. This means long-term outcomes are not fully established. Research describes that the results apply only to the populations studied, and data for certain groups (such as specific comorbidity-defined populations or children) remains insufficient.

Furthermore, comparative evidence is lacking in some therapeutic areas, where studies have primarily compared the drug against a placebo rather than other current standard approaches. This evidence highlights what is known — and what is still uncertain — about the drug under specific research conditions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Diclofenac EG (FAQ)

Q: How quickly can I expect Diclofenac EG to start working?

Oral forms of diclofenac generally begin absorption relatively soon after ingestion. However, official regulatory information indicates that the actual time to symptomatic change can vary, and taking the medicine with food may delay this initial process. The drug's active substance is eliminated from the bloodstream with a relatively short half-life, but the beneficial effect may continue for a longer period.

Q: Can Diclofenac EG be used for period pain?

Yes, official product information for some diclofenac formulations lists the symptomatic treatment of pain associated with menstrual cramps (dysmenorrhea) as an approved indication. The decision for its use is based on individual patient assessment.

Q: Is Diclofenac EG available without a prescription in some places?

The legal status of diclofenac varies by country and formulation. Depending on the local regulatory body, lower-strength tablets or certain topical gels may be available over the counter (OTC), while stronger systemic forms typically require a prescription-only medicine (POM) status.

Q: How long does the effect of a Diclofenac EG dose usually last?

The active substance, diclofenac, has a relatively short terminal half-life in the bloodstream—around two hours. However, the pain-relieving and anti-inflammatory effects can persist longer. This duration of effect aligns with the prescribed dosing frequency for immediate-release forms.

Q: Can taking Diclofenac EG cause dizziness or drowsiness?

Yes, official safety documents list dizziness, headache, and drowsiness (somnolence) as known side effects. Official prescribing information advises caution regarding activities like driving or operating machinery if these effects are experienced.

Q: Are there any known issues with taking Diclofenac EG long-term?

Official warnings state that the risk of serious side effects, including serious cardiovascular events (like heart attack or stroke) and gastrointestinal bleeding or ulceration, may increase with higher doses and longer duration of use. Regulatory guidance therefore emphasizes using the shortest possible duration of treatment.

Q: What is the maximum time a person should take Diclofenac EG?

Official prescribing guidance strongly emphasizes using the lowest effective dose for the shortest possible duration for all patients. For many acute, non-prescription uses, regulatory guidance notes the need for healthcare consultation if the medicine is used for longer than a specified duration, such as 7 days.

Q: Is Diclofenac EG suitable for people with high blood pressure?

Regulatory documents state that use requires caution in patients with high blood pressure (hypertension) or cardiovascular risk factors, as fluid retention and increased blood pressure are listed potential effects. Furthermore, high-dose, long-term use is typically contraindicated in patients with established cardiovascular disease, which includes certain classes of uncontrolled hypertension.

Q: Can Diclofenac EG affect kidney function?

Regulatory information indicates that diclofenac can cause a dose-dependent reduction in kidney function by inhibiting substances called prostaglandins, which help maintain renal blood flow. Official prescribing information highlights that individuals with pre-existing kidney issues or those taking certain interacting medications may be at an increased risk of renal toxicity.

Q: What are the signs that Diclofenac EG might not be agreeing with me?

Official patient counseling information specifies symptoms that warrant immediate discontinuation of the medication and prompt medical attention. These include signs of serious reactions such as chest pain, shortness of breath, unexplained bleeding (like black, tarry stools), severe stomach pain, or severe allergic reactions (like swelling of the face or throat).

Q: Can Diclofenac EG be taken by someone with asthma?

Diclofenac is contraindicated for patients with a history of asthma, hives (urticaria), or other allergic-type reactions after taking aspirin or any other Nonsteroidal Anti-inflammatory Drug (NSAID). This is due to the potential for severe, anaphylactic reactions.

Q: Can I take other pain relievers like paracetamol while using Diclofenac EG?

Paracetamol (acetaminophen) is frequently cited in public health guidance as generally having no known negative interaction with diclofenac. Conversely, diclofenac is not typically recommended for use concurrently with other similar anti-inflammatory painkillers, such as aspirin, ibuprofen, or naproxen.

Q: Is Diclofenac EG a common trigger for heartburn?

Yes, regulatory documents and patient information leaflets list heartburn (pyrosis) as a known gastrointestinal side effect. Other common GI symptoms include nausea, vomiting, indigestion, and general stomach pain.

Q: Is Diclofenac EG considered a strong pain reliever?

Diclofenac is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is recognized in authoritative medical literature as being among the more potent conventional NSAIDs used globally for its analgesic and anti-inflammatory properties.

Q: What is the classification of Diclofenac EG for safety?

The official safety profile is complex, addressing several areas. For example, it is specifically noted that use should be avoided in the third trimester of pregnancy. It also includes detailed warnings for use in pediatric, geriatric, and renally or hepatically impaired populations, mandating careful consideration in these groups.

Q: Does Diclofenac EG interact with common supplements like magnesium or turmeric?

While specific supplement interactions are not comprehensively detailed in all product labels, regulatory guidance notes potential concerns regarding the concurrent use of herbal remedies that may affect bleeding or clotting. For example, some sources note that supplements like turmeric might affect platelet function, raising concerns about an increased risk of bleeding when combined with diclofenac.

Q: What is the 'Black Box Warning' (if any) associated with Diclofenac?

Systemic (taken internally) diclofenac formulations carry an official Boxed Warning (often referred to as a 'Black Box Warning') from the U.S. FDA. This warning highlights the risks of serious cardiovascular thrombotic events (such as heart attack or stroke) and serious gastrointestinal adverse events (including bleeding and ulceration).

Q: Can Diclofenac EG cause skin sensitivity to the sun?

Yes, official documentation lists photosensitivity (increased skin sensitivity to sunlight) as a potential adverse reaction. This is particularly noted in regulatory information associated with the use of the topical gel and other external formulations.

Q: What does evidence show about Diclofenac EG for back pain?

Research and studies referenced in regulatory documents have explored diclofenac's role in the relief of general acute pain. Specific formulations, such as topical patches and systemic tablets, have been examined for their use in conditions including chronic low back pain.

Q: Does Diclofenac EG affect fertility?

Official product information states that taking anti-inflammatory medicines like diclofenac, particularly at high doses or for extended periods, may temporarily affect ovulation in women. This effect on ovulation is documented in regulatory information as being reversible upon discontinuation of the medicine.

Q: What are the common signs of an interaction with other medicines?

The signs of a drug interaction can vary widely depending on the interacting drug. Official patient information describes symptoms for which patients should be vigilant when the drug is used concurrently with other medicines, such as increased bleeding or bruising (when combined with blood thinners), changes in your regular pattern of urination (with certain diuretics), or signs of confusion and nausea (with drugs like lithium).

Q: How is the safety of Diclofenac EG tracked by regulatory agencies?

The safety of this medicine is continuously monitored through pharmacovigilance programs run by government bodies such as the EMA and FDA. These agencies conduct periodic safety reviews of drug classes like NSAIDs, which can lead to updates in the official prescribing information, including new warnings and restrictions.

Q: Can Diclofenac EG cause changes in mood or anxiety?

Official regulatory documents list effects on the central nervous system and psychiatric systems as potential, though less common, adverse reactions. These potential effects include the occurrence of anxiety, nervousness, depression, and trouble sleeping (insomnia).

Advertisements

How should Diclofenac EG be stored and disposed of?

How to Store and Dispose of Diclofenac EG?

This information is based on official government regulatory documents and prescribing information.

Official Storage Requirements

Condition Requirement
Temperature Store below 25 C or 30 C (check specific label).
Protection Keep in the original container, protected from moisture and light.
Handling Do not freeze. Keep tightly closed.
Safety Keep out of the reach and sight of children.

Official Disposal Instructions

Unused or expired Diclofenac must not be disposed of in household trash, drains, or wastewater, to avoid release to the environment. Dispose of the medicine and its container in accordance with local regulations, typically by returning it to a pharmacy or an authorized pharmaceutical waste collection program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diclofenac EG found in:

A-Z Index: